JNJ-1661010 – 50 mg

Brand:
Cayman
CAS:
681136-29-8
Storage:
-20
UN-No:
Non-Hazardous - /

Fatty acid amide hydrolase (FAAH) degrades N-acyl ethanolamines, including the endocannabinoid arachidonoyl ethanolamide (AEA). JNJ-1661010 is a selective inhibitor of FAAH (IC50s = 34 and 33 nM in rat and human, respectively) that is able to cross the blood-brain barrier.{22625} At 20 mg/kg, JNJ-1661010 has been shown to elevate levels of AEA in rat brain.{22625} This compound has been used to examine the contribution of endocannabinoid signaling in experimental fibrosis.{22644}  

 

SKU: - Category:

Description

A selective inhibitor of FAAH (IC50s = 34 and 33 nM in rat and human, respectively) that is able to cross the blood-brain barrier


Formal name: N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)-1-piperazinecarboxamide

Synonyms: 

Molecular weight: 365.5

CAS: 681136-29-8

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids